STAT3 and non-small cell lung carcinoma: We correlated the expression of hamartin, p-TSC2 and p-mTOR with expression data concerning epidermal growth factor receptor mutations in non-small cell lung cancer and their influence on downstream Akt, MAPK and Stat3 signaling [21].